Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1998-01-13
2000-01-11
McKane, Joseph K.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 137, 424 181, 424 189, 514186, 514304, 546 4, 546125, 546132, A61K 31435, A61K 5104, C07D40114
Patent
active
060132426
ABSTRACT:
Biologically active derivatives of the tropane ring system are provided which selectively bind either to the 5-HT or DA reuptake site, leading to compounds which have use for the treatment of clinical depression, attention deficit disorder, obesity and cocaine addiction.
REFERENCES:
patent: 5128118 (1992-07-01), Carroll et al.
patent: 5262428 (1993-11-01), Davies et al.
patent: 5288872 (1994-02-01), Davies et al.
patent: 5342949 (1994-08-01), Davies et al.
patent: 5369113 (1994-11-01), Moldt et al.
patent: 5374636 (1994-12-01), Moldt et al.
patent: 5380848 (1995-01-01), Kuhar et al.
patent: 5391744 (1995-02-01), Kozikowski
patent: 5439666 (1995-08-01), Neumeyer et al.
patent: 5591854 (1997-01-01), Davies
patent: 5760055 (1998-06-01), Davies
Childers Steven R.
Davies Huw M. L.
Kong Norman
McKane Joseph K.
The Research Foundation of State University of New York
Wake Forest University
LandOfFree
Tropane derivatives with selective binding to the serotonin reup does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tropane derivatives with selective binding to the serotonin reup, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tropane derivatives with selective binding to the serotonin reup will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1459648